What does the Global Mammography Horizon report cover?

The report covers the global mammography market and broader breast imaging ecosystem from 2024A to 2035F. It includes dedicated mammography systems, FFDM, digital breast tomosynthesis, contrast-enhanced mammography, mammography AI/workflow, service and aftermarket, mobile mammography, interventional breast pathways, breast ultrasound, and breast MRI adjacencies.

Which companies are discussed in the report?

The report discusses systems OEMs, AI vendors, workflow platforms, interventional breast pathway companies, provider networks, mobile access models, China/value-tier challengers, detector suppliers, and CEM/photon-counting enabling-stack companies. Examples include Hologic, GE HealthCare, Siemens Healthineers, Fujifilm, Canon Medical, United Imaging, Wandong, ScreenPoint, Lunit/Volpara, RadNet/DeepHealth/iCAD, Visage/Pro Medicus, Sectra, Mammotome, BD, Merit Medical, Varex, Bayer, Bracco, and Guerbet.

What is the Core Mammography Market?

The Core Mammography Market includes dedicated mammography systems, mammography-specific service contracts, mammography-specific software and workstations, and mammography AI/workflow revenue. It does not blend in breast biopsy, breast ultrasound, or breast MRI without explicit bridge labeling.

How does the report treat AI revenue?

The report separates vendor-net AI/workflow revenue from provider-gross AI economics. Vendor-net revenue refers to software revenue booked by vendors, OEMs, or workflow platforms. Provider-gross economics include productivity, patient-pay, reimbursement, recall management, and downstream workflow value captured by providers.

How is this report different from a standard mammography equipment market report?

A standard equipment report often focuses on unit shipments, installed base, ASPs, and system revenue. This Horizon report adds market-structure analysis, AI monetization, CEM strategy, interventional breast pathway economics, breast US/MRI adjacencies, regional archetypes, competitive control planes, and strategic frameworks for commercial decision-making.

Who should buy this report?

This report is designed for medical imaging OEMs, breast health strategy teams, AI and workflow vendors, enterprise imaging platforms, biopsy and interventional breast companies, detector and contrast suppliers, provider networks, investors, private equity, distributors, and public-sector screening or procurement stakeholders.

GTM Intelligence Hub – Marketstrat

Azra AI, Blackford and Telix: The Cost of Delivering Imaging Growth – Oct 23, 2026

GE HealthCare, MARS Bioimaging, QT Imaging and Hyperfine Show Why Imaging Capacity Is Moving from Rooms to Networks – August 7, 2026

Medical imaging capacity is entering a new phase. Scanner count…

Caristo, DeepHealth, ThinkSono and 4DMedical Shift Imaging AI Toward Service-Line Economics – July 31, 2026

Medical imaging AI is entering a more demanding commercialization phase.…

Johnson & Johnson, GE HealthCare, DeepHealth and CARPL.ai Shift Imaging AI Toward Decision Infrastructure – July 24, 2026

Johnson & Johnson, GE HealthCare, DeepHealth and CARPL.ai show imaging…

CMS, GE HealthCare, Sectra and Provect AI Reshape Imaging Capacity – July 17, 2026

Midjourney Medical, Butterfly Network and AIRS Medical Shift Imaging AI Toward Distribution, Capacity and Regulated Updates – June 19, 2026

Consumer-led imaging, embedded ultrasound components, MRI capacity software and FDA’s…

RadNet/DeepHealth, GE HealthCare and Rad AI Turn Reporting AI Into Imaging’s Control Layer – June 12, 2026

The week ending June 12 showed imaging AI moving beyond…

Imaging AI Moves From Point Solutions to Platform Control – June 5, 2026

The week ending June 5, 2026 showed imaging AI becoming…